Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Chemoradiotherapy × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 7 Oropharyngeal Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 NSCLC 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1 Resectable Esophageal Cancer 1 Rectal Malignant Neoplasms 1 Radiation Injuries 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Cancer Non-resectable 1 Ototoxicity 1

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡